Jury Selection Begins in Alabama for Trial of 70 Pharmaceutical Firms
Jury selection is beginning in the next trial of Alabama’s lawsuits against more than 70 pharmaceutical companies for allegedly overcharging the state’s Medicaid program.
A jury is being selected June 17 in the trial against drug companies Novartis Pharmaceuticals and SmithKline Beecham Corp. before Montgomery County Circuit Judge Charles Price. Opening statements in the trial are expected to begin tomorrow.
In the first trial in February, a state court jury awarded the state $215 million in its Medicaid drug price fraud case against AstraZeneca Pharmaceuticals LP.
Novartis produces a number of drugs, including the high blood pressure medications Diovan and Tekturna. SmithKline makes the asthma medication Advair and other prescription drugs.
Copyright 2024 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Popular Today
- Work Safety Group Releases List of ‘Dirty Dozen’ Employers
- Jury Awards $80M to 3 Former Zurich NA Employees for Wrongful Termination
- California Sees Two More Property Insurers Withdraw From Market
- Florida’s Home Insurance Industry May Be Worse Than Anyone Realizes
Popular This Month
- California Chiropractor Sentenced to 54 Years for $150M Workers’ Comp Scheme
- Poll: Consumers OK with AI in P/C Insurance, but Not So Much for Claims and Underwriting
- Millions of Recalled Hyundai and Kia Vehicles, With Dangerous Defect, Remain on Road
- Report: Vehicle Complexity, Labor ‘Reshaping’ Auto Insurance and Collision Repair